Showing results (531-540 of 773) with videos related to
Sort By:
Pageof 78
Arzneimittel-Forschung|January 1, 1984
[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human]C Staiger, B Koroknay, J X DeVries, et al.The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|August 18, 2025
Myalgia and Rigidity as Adverse Effects of Trametinib TherapyCharles J Weeks, Victoria Frame, Rohan Vuppala, et al.Neuroimage|December 3, 2014
Calibrating the BOLD response without administering gases: comparison of hypercapnia calibration with calibration using an asymmetric spin echoNicholas P Blockley, Valerie E M Griffeth, Aaron B Simon, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 1, 1987
Feasibility and effectiveness of school-based relaxation in lowering blood pressureC K Ewart, W L Harris, M M Iwata, et al.Scientific Reports|October 6, 2021
A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalographyOlivier B Simon, Isabelle Buard, Donald C Rojas, et al.Gut|February 1, 1986
Cimetidine prophylaxis for gastrointestinal bleeding in an intensive care unitA Groll, J B Simon, R D Wigle, et al.Human Genetics|February 1, 1992
Carrier detection and prenatal diagnosis of cystic fibrosis using an intragenic TA-repeat polymorphismE Mornet, C Chateau, B Simon-Bouy, et al.Journal of Clinical Gastroenterology|June 1, 1986
A single nighttime dose of ranitidine 300 mg versus ranitidine 150 mg twice daily in the acute treatment of duodenal ulcer: a European multicenter trialB Simon, G Bianchi Porro, M Cremer, et al.Cancer Research|August 2, 2001
Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumorsN Lubomierski, M Kersting, T Bert, et al.Zeitschrift Fur Gastroenterologie|September 1, 1990
Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteersB Simon, P Müller, M Hartmann, et al.Pageof 78